Skip to Content
Merck
  • Azodicarbonamide as a new T cell immunosuppressant: synergy with cyclosporin A.

Azodicarbonamide as a new T cell immunosuppressant: synergy with cyclosporin A.

Clinical immunology (Orlando, Fla.) (2001-06-21)
J Tassignon, M Vandevelde, M Goldman
ABSTRACT

We recently demonstrated that azodicarbonamide is an immunosuppressive compound that inhibits calcium mobilization in T lymphocytes. In this study, we show that azodicarbonamide prevents the progression of human CD4+ T lymphocytes into the G1 phase of the cell cycle, inhibits their blastogenesis, down-regulates their membrane expression of CD25 and CD69, and decreases their transcription of cytokine genes. Addition of the calcium ionophore A23187 completely restores T cell proliferation in the presence of azodicarbonamide. Furthermore, azodicarbonamide synergizes with cyclosporin A to inhibit CD4+ T cell proliferation. In conclusion, the immunosuppressive action of azodicarbonamide is mainly related to its effect on the calcium mobilization machinery and is synergistic with that of calcineurin inhibitors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Azodicarboxamide, 97%